Mammographic practice and dosimetry in Britain

3D-printed breast phantom for multi-purpose and multi-modality imaging

Background

Breast imaging technology plays an important role in breast cancer planning and treatment. Recently, three-dimensional (3D) printing technology has become a trending issue in phantom constructions for medical applications, with its advantages of being customizable and cost-efficient. However, there is no current practice in the field of multi-purpose breast phantom for quality control (QC) in multi-modalities imaging. The purpose of this study was to fabricate a multi-purpose breast phantom with tissue-equivalent materials via a 3D printing technique for QC in multi-modalities imaging.

Methods

We used polyvinyl chloride (PVC) based materials and a 3D printing technique to construct a breast phantom. The phantom incorporates structures imaged in the female breast such as microcalcifications, fiber lesions, and tumors with different sizes. Moreover, the phantom was used to assess the sensitivity of lesion detection, depth resolution, and detectability thresholds with different imaging modalities. Phantom tissue equivalent properties were determined using computed tomography (CT) attenuation [Hounsfield unit (HU)] and magnetic resonance imaging (MRI) relaxation times.

Results

The 3D-printed breast phantom had an average background value of 36.2 HU, which is close to that of glandular breast tissue (40 HU). T1 and T2 relaxation times had an average relaxation time of 206.81±17.50 and 20.22±5.74 ms, respectively. Mammographic imaging had improved detection of microcalcification compared with ultrasound and MRI with multiple sequences [T1WI, T2WI and short inversion time inversion recovery (STIR)]. Soft-tissue lesion detection and cylindrical tumor contrast were superior with mammography and MRI compared to ultrasound. Hemispherical tumor detection was similar regardless of the imaging modality used.

Conclusions

We developed a multi-purpose breast phantom using a 3D printing technique and determined its value for multi-modal breast imaging studies.

Two-dimensional breast dosimetry improved using three-dimensional breast image data

Conventional mammographic dosimetry has been developed over the past 40 years. Prior to the availability of high-resolution three-dimensional breast images, certain assumptions about breast anatomy were required. These assumptions were based on the information evident on two-dimensional mammograms; they included assumptions of thick skin, a uniform mixture of glandular and adipose tissue, and a median breast density of 50%. Recently, the availability of high-resolution breast CT studies has provided more accurate data about breast anatomy, and this, in turn, has provided the opportunity to update mammographic dosimetry. Based on hundreds of data sets on breast CT volume, a number of studies were performed and reported which have shed light on the basic breast anatomy specific to dosimetry in mammography. It was shown that the average skin thickness of the breast was approximately 1.5 mm, instead of the 4 or 5 mm in the past. In another study, 3-D breast CT data sets were used for validation of the 2-D algorithm developed at the University of Toronto, leading to data suggesting that the overall average breast density is of the order of 16-20%, rather than the previously assumed 50%. Both of these assumptions led to normalized glandular dose (DgN) coefficients which are higher than those of the past. However, a comprehensive study on hundreds of breast CT data sets confirmed the findings of other investigators that there is a more centralized average location of glandular tissue within the breast. Combined with Monte Carlo studies for dosimetry, when accurate models of the distribution of glandular tissue were used, a 30% reduction in the radiation dose (as determined by the DgN coefficient) was found as an average across typical molybdenum and tungsten spectra used clinically. The 30% average reduction was found even when the thinner skin and the lower average breast density were considered. The article reviews three specific anatomic observations made possible based on high-resolution breast CT data by several different research groups. It is noted that, periodically, previous assumptions pertaining to dosimetry can be updated when new information becomes available, so that more accurate dosimetry is achieved. Dogmatic practices typically change slowly, but it is hoped that the medical physics community will continue to evaluate changes in DgN coefficients such that they become more accurate.

Dosimetry in x-ray-based breast imaging

The estimation of the mean glandular dose to the breast (MGD) for x-ray based imaging modalities forms an essential part of quality control and is needed for risk estimation and for system design and optimisation. This review considers the development of methods for estimating the MGD for mammography, digital breast tomosynthesis (DBT) and dedicated breast CT (DBCT). Almost all of the methodology used employs Monte Carlo calculated conversion factors to relate the measurable quantity, generally the incident air kerma, to the MGD. After a review of the size and composition of the female breast, the various mathematical models used are discussed, with particular emphasis on models for mammography. These range from simple geometrical shapes, to the more recent complex models based on patient DBCT examinations. The possibility of patient-specific dose estimates is considered as well as special diagnostic views and the effect of breast implants. Calculations using the complex models show that the MGD for mammography is overestimated by about 30% when the simple models are used. The design and uses of breast-simulating test phantoms for measuring incident air kerma are outlined and comparisons made between patient and phantom-based dose estimates. The most widely used national and international dosimetry protocols for mammography are based on different simple geometrical models of the breast, and harmonisation of these protocols using more complex breast models is desirable.

Diagnostic reference levels in digital mammography: a systematic review

This study aims to review the literature on existing diagnostic reference levels (DRLs) in digital mammography and methodologies for establishing them. To this end, a systematic search through Medline, Cinahl, Web of Science, Scopus and Google scholar was conducted using search terms extracted from three terms: DRLs, digital mammography and breast screen. The search resulted in 1539 articles of which 22 were included after a screening process. Relevant data from the included studies were summarised and analysed. Differences were found in the methods utilised to establish DRLs including test subjects types, protocols followed, conversion factors employed, breast compressed thicknesses and percentile values adopted. These differences complicate comparison of DRLs among countries; hence, an internationally accepted protocol would be valuable so that international comparisons can be made.

The development of mammography

This review traces the development of mammography physics over the last 50 years, concentrating mainly on technological changes and their inter-relations. It has been written for physicists with no specific mammography experience but a general interest in radiology, as much as for those with recent involvement in mammography. Topics covered include industrial film, xerography, intensifying screens, x-ray tube developments, image quality test objects, patient dose and performance checks. Some of these developments were necessary before population screening of healthy women could be considered, while others have resulted from increased opportunities for equipment manufactures which screening programmes created. The standpoint of this review is that of a physicist with long experience in a UK centre where mammography was performed on dedicated equipment well over 40 years ago and where screening has been performed continuously for 30 years.

Dosimetric implications of age related glandular changes in screening mammography

The UK National Health Service Breast Screening Programme is currently organized to routinely screen women between the ages of 50 and 64, with screening for older women available on request. The lower end of this age range closely matches the median age for the menopause (51 years), during which significant changes in the composition of the breast are known to occur. In order to quantify the dosimetric effect of these changes, radiographic factors and compressed breast thickness data for a cohort of 1258 women aged between 35 and 79 undergoing breast screening mammography have been used to derive estimates of breast glandularity and mean glandular dose (MGD), and examine their variation with age. The variation of mean radiographic exposure factors with age is also investigated. The presence of a significant number of age trial women within the cohort allowed an extended age range to be studied. Estimates of MGD including corrections for breast glandularity based on compressed breast thickness only, compressed breast thickness and age and for each individual woman are compared with the MGD based on the conventional assumption of a 50:50 adipose/glandular composition. It has been found that the use of the conventional 50:50 assumption leads to overestimates of MGD of up to 13% over the age range considered. By using compressed breast thickness to estimate breast glandularity, this error range can be reduced to 8%, whilst age and compressed breast thickness based glandularity estimates result in an error range of 1%.

Breast dosimetry

The estimation of the absorbed dose to the breast is an important part of the quality control of the mammographic examination. Knowledge of breast dose is essential for the design and performance assessment of mammographic imaging systems. This review gives a historical introduction to the measurement of breast dose. The mean glandular dose (MGD) is introduced as an appropriate measure of breast dose. MGD can be estimated from measurements of the incident air kerma at the surface of the breast and the application of an appropriate conversion factor. Methods of calculating and measuring this conversion factor are described and the results discussed. The incident air kerma itself may be measured for patients or for a test phantom simulating the breast. In each case the dose may be determined using TLD measurements, or known exposure parameters and measurements of tube output. The methodology appropriate to each case is considered and the results from sample surveys of breast dose are presented. Finally the various national protocols for breast dosimetry are compared.

Recent developments in breast imaging

A review of breast imaging has already appeared in 1982 in this journal. Consequently, the present article concentrates on a discussion of only those developments of a more recent nature. Although the emphasis is placed on the physical aspects of the different imaging methods concerned, the essential factors relating to the clinical background and the associated radiation risk are also outlined. The completeness of detail depends on the present clinical importance of the method under discussion. X-ray mammography, which is still the most important breast imaging technique and has proved to be an effective method for breast cancer screening, is therefore treated in greater detail. Since the early 1980s, ultrasound B-mode scanning has evolved to an indispensable adjunct to x-ray mammography. For Doppler sonography, diaphanography, contrast-enhanced MRI, CT and DSA, the visualization of a tumour depends essentially on the enhanced vascularity of the lesion. Whether this will prove to be a reliable indicator for malignancy remains to be shown in controlled clinical studies. Common to all imaging systems is the increasing use of digital methods for signal processing, which also offers the possibility of computer-aided diagnosis by texture analysis and pattern recognition.

Films, screens and cassettes for mammography

Various film-screen combinations intended for mammography have been compared for image quality and for dose. Image quality was assessed as in an earlier paper, using a test object having details which are both realistic and quantitative. Relative doses required to give film densities of 1.0 were measured. The Kodak MinR-MinR combination was taken as a standard against which others were compared, and in general a lower dose was accompanied by poorer image quality. The Fuji NH film with Fuji Hi-Mammo screen was the sole exception, giving slightly better image quality at about half the dose required by the MinR combination. A number of cassettes were also compared with each other and with evacuated envelopes. The Dupont Cronex cassette and three carbon-fibre fronted cassettes all performed well in image quality.

A comparative study of films and screens for mammography

Ten films and six screens suitable for mammography have been compared for image quality using a realistic quantitative phantom under controlled conditions. The best screen was Min R (Kodak), but three black and white films, Min R (Kodak), Fuji II NC (Fuji) and MR3 (Agfa-Gevaert), scored highly. Patient dose was also considered and, with these three films, small gains in image quality were balanced by small increases in dose. Medichrome Blue film, however, gave the highest score of all, and did so for a dose that was less than the highest. These results were confirmed on a second phantom of entirely different design.

Tungsten anode tubes with K-edge filters for mammography

A number of authors have calculated the optimum X-ray energies for mammography using, as a criterion, the maximum signal to noise ratio (SNR) per unit dose to the breast, or conversely the minimum exposure for constant SNR. Filters having absorption edges at appropriate energy positions have been used to modify the shape of tungsten anode spectra to bring them close to the calculated optimum. The suitability of such spectra for practical use has been assessed by comparing both the film image quality and the incident breast dose obtained using a K-edge filtered tungsten anode tube with that obtained using a molybdenum anode tube. Image quality has been assessed both by using a "random" phantom and by comparing mammograms of women attending a screening clinic where one breast was radiographed using a filtered tungsten anode tube and the other using a standard molybdenum anode unit. Relative breast doses were estimated from both ionisation chamber measurements with a phantom and thermoluminescent dosimetry measurements on the breast. The film image quality assessment indicated that the filtered tungsten anode tube gave results which were not significantly different from those obtained with a molybdenum anode tube for a tissue thickness of about 4 cm and which were better for larger breast thicknesses. The dose could be reduced to between one-half and one-third with the filtered tungsten anode tube.